{"id":4139,"date":"2017-06-06T18:42:00","date_gmt":"2017-06-06T16:42:00","guid":{"rendered":"https:\/\/patientenstimme-sma.de\/?page_id=4139"},"modified":"2026-03-16T21:04:51","modified_gmt":"2026-03-16T20:04:51","slug":"spinraza-zugelassen","status":"publish","type":"post","link":"https:\/\/smartunity.space\/stories\/thema\/spinraza-zugelassen\/","title":{"rendered":"Spinraza zugelassen"},"content":{"rendered":"\n<div class=\"wp-block-group alignwide is-layout-flow wp-block-group-is-layout-flow\" style=\"border-radius:10px;padding-top:20px;padding-right:20px;padding-bottom:20px;padding-left:20px\">\n<p class=\"tw-text-wide\">Der Tag X.<\/p>\n\n\n\n<p class=\"tw-text-wide\">Es gab ja schon l\u00e4nger, immermal wieder Berichte \u00fcber m\u00f6glicherweise bald kommende erste Medikamente zur Behandlung der spinalen Muskelatrophie. Beispiel Valproins\u00e4ure oder Olesoxime, aber leider ist da bisher nichts draus geworden.<\/p>\n\n\n\n<p class=\"tw-text-wide\">Mit Nusinersen, einem <a href=\"https:\/\/de.wikipedia.org\/wiki\/Antisense-Oligonukleotid\" data-type=\"URL\" data-id=\"https:\/\/de.wikipedia.org\/wiki\/Antisense-Oligonukleotid\" target=\"_blank\" rel=\"noreferrer noopener\">Antisense Oligonukleotid<\/a>, mit dem Markennamen <a rel=\"noreferrer noopener\" aria-label=\"SPINRAZA\u00ae (\u00f6ffnet in neuem Tab)\" href=\"https:\/\/www.spinraza.com\/\" target=\"_blank\">Spinraza\u00ae<\/a> des Biotechnologieunternehmens <a rel=\"noreferrer noopener\" aria-label=\"Biogen (\u00f6ffnet in neuem Tab)\" href=\"https:\/\/www.biogen.de\" target=\"_blank\">Biogen\u00ae<\/a> ist nun zum allerersten mal ein Medikament verf\u00fcgbar &#8230;. endlich! Nusinersen wirkt dabei auf das SMN2 Backup Gen und erh\u00f6ht die Bildung des wichtigen SMN Proteins. Wir werden sehen was es bringt. Allen viel Erfolg zur Behandlung gew\u00fcnscht!<\/p>\n\n\n\n<p class=\"tw-text-wide\"><a href=\"https:\/\/sma.selfempowered.net\/wp-content\/uploads\/sites\/2\/2018\/05\/PM-Biogen-Zulassung-Spinraza.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Die offizielle Pressemitteilung von Biogen zur Zulassung von SPINRAZA\u00ae zum ansehen und auch downloaden.<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Der Tag X. Es gab ja schon l\u00e4nger, immermal wieder Berichte \u00fcber m\u00f6glicherweise bald kommende erste Medikamente zur Behandlung der spinalen Muskelatrophie. Beispiel Valproins\u00e4ure oder Olesoxime, aber leider ist da bisher nichts draus geworden. Mit Nusinersen, einem Antisense Oligonukleotid, mit dem Markennamen Spinraza\u00ae des Biotechnologieunternehmens Biogen\u00ae ist nun zum allerersten mal ein Medikament verf\u00fcgbar &#8230;. [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"only-view","format":"standard","meta":{"activitypub_content_warning":"","activitypub_content_visibility":"","activitypub_max_image_attachments":0,"activitypub_interaction_policy_quote":"anyone","activitypub_status":"","footnotes":""},"categories":[1],"tags":[58],"class_list":["post-4139","post","type-post","status-publish","format-standard","hentry","category-thema","tag-smanews"],"_links":{"self":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/4139","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/comments?post=4139"}],"version-history":[{"count":1,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/4139\/revisions"}],"predecessor-version":[{"id":39903,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/posts\/4139\/revisions\/39903"}],"wp:attachment":[{"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/media?parent=4139"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/categories?post=4139"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/smartunity.space\/stories\/wp-json\/wp\/v2\/tags?post=4139"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}